Literature DB >> 11207593

Bacterial inhibition of phagocytosis.

J D Ernst1.   

Abstract

The concerted study of molecular mechanisms of phagocytosis and the inhibition of phagocytosis by specific products of extracellular bacterial pathogens has borne considerable fruit. The importance of tyrosine phosphorylation and of the Rho family of GTPases has become clear to cell biologists, but pathogenic bacteria recognized the importance of these signalling pathways in phagocytic cells long ago. The discoveries described in this review are only the beginning. The simultaneous pursuit of the mechanisms and molecules involved in the initiation and regulation of phagocytosis and that pathogenic bacteria use to inhibit phagocytosis will surely identify more interesting pathways on each side of the contest. Are there any obvious possibilities? There are several bacterial factors that have the potential to inhibit known mechanisms of phagocytosis. Clostridium species, for example, make a number of exotoxins of interest. Clostridium botulinum and Clostridium tetani neurotoxins inactivate the regulated secretory machinery by proteolytic cleavage of SNARE proteins, and targets of tetanus toxin and botulinum b toxin inhibit the exocytotic delivery of membrane vesicles needed for phagocytosis of large particles (Hackam et al., 1998). Moreover, the C3 exotoxin of C. botulinum catalyses ADP ribosylation and inactivation of rho family GTPases (Wiegers et al., 1991), and toxins A and B of C. difficile UDP-glucosylate and inactivate rho GTPases and thereby disrupt the actin cytoskeleton (Just et al., 1995a,b). However, as Clostridia lack the machinery for type III secretion, these proteins are not rapidly targeted to the phagocyte cytoplasm. More searching may reveal a pathogen that has combined the type III secretory machinery with clostridia toxin-like substrates. A potentially unique strategy for remaining outside phagocytes is exhibited by Helicobacter pylori, which contain a type IV secretion system. Unopsonized virulent strains of H. pylori bind readily to macrophages but are only internalized after a delay of several minutes. Such a delay appears to be sufficient for the bacteria to remain extracellular (Allen et al., 2000). Elucidation of the mechanism used by H. pylori to delay phagocytosis may reveal one or more novel virulence factors as well as one or more novel targets in the phagocyte that will add to the understanding of a fundamental process in host defence. Another field ripe for further mechanistic investigation is complement receptor-mediated phagocytosis. Dedicated study of the molecular events and molecular mediators of phagocytosis downstream of CR3 is likely to reveal interesting differences from FcgammaR phagocytosis and is just as likely to reveal that microbes have discovered unique mechanisms for circumventing them. Study of extracellular pathogens and the mechanisms that they use to remain outside phagocytic cells has revealed a great deal about the initial encounter between pathogen and phagocyte. We can look forward to additional discoveries about the host-pathogen interactions and the mechanisms and factors that each side uses to battle against the other.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11207593     DOI: 10.1046/j.1462-5822.2000.00075.x

Source DB:  PubMed          Journal:  Cell Microbiol        ISSN: 1462-5814            Impact factor:   3.715


  29 in total

1.  Vav regulates activation of Rac but not Cdc42 during FcgammaR-mediated phagocytosis.

Authors:  Jayesh C Patel; Alan Hall; Emmanuelle Caron
Journal:  Mol Biol Cell       Date:  2002-04       Impact factor: 4.138

2.  Structural and functional cellular changes induced by Burkholderia pseudomallei rhamnolipid.

Authors:  S Häussler; M Rohde; N von Neuhoff; M Nimtz; I Steinmetz
Journal:  Infect Immun       Date:  2003-05       Impact factor: 3.441

3.  Entry and intracellular replication of Escherichia coli K1 in macrophages require expression of outer membrane protein A.

Authors:  Sunil K Sukumaran; Hiroyuki Shimada; Nemani V Prasadarao
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

4.  Bracoviruses contain a large multigene family coding for protein tyrosine phosphatases.

Authors:  Bertille Provost; Paola Varricchio; Eloisa Arana; Eric Espagne; Patrizia Falabella; Elisabeth Huguet; Raffaella La Scaleia; Laurence Cattolico; Marylène Poirié; Carla Malva; Julie A Olszewski; Francesco Pennacchio; Jean-Michel Drezen
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

5.  Aging-Impaired Filamentous Actin Polymerization Signaling Reduces Alveolar Macrophage Phagocytosis of Bacteria.

Authors:  Zhigang Li; Yang Jiao; Erica K Fan; Melanie J Scott; Yuehua Li; Song Li; Timothy R Billiar; Mark A Wilson; Xueyin Shi; Jie Fan
Journal:  J Immunol       Date:  2017-09-25       Impact factor: 5.422

6.  Encapsulated Streptococcus suis inhibits activation of signaling pathways involved in phagocytosis.

Authors:  Mariela Segura; Marcelo Gottschalk; Martin Olivier
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

7.  Unsaturated fatty acids promote the phagocytosis of P. aeruginosa and R. equi by RAW264.7 macrophages.

Authors:  Stephanie Adolph; Herbert Fuhrmann; Julia Schumann
Journal:  Curr Microbiol       Date:  2012-08-18       Impact factor: 2.188

8.  Fcγ receptor I alpha chain (CD64) expression in macrophages is critical for the onset of meningitis by Escherichia coli K1.

Authors:  Rahul Mittal; Sunil K Sukumaran; Suresh K Selvaraj; David G Wooster; M Madan Babu; Alan D Schreiber; J Sjef Verbeek; Nemani V Prasadarao
Journal:  PLoS Pathog       Date:  2010-11-18       Impact factor: 6.823

9.  Inhibition of phagocytosis by Haemophilus ducreyi requires expression of the LspA1 and LspA2 proteins.

Authors:  Merja Vakevainen; Steven Greenberg; Eric J Hansen
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

10.  Auxiliary role for D-alanylated wall teichoic acid in Toll-like receptor 2-mediated survival of Staphylococcus aureus in macrophages.

Authors:  Akiko Shiratsuchi; Kaori Shimizu; Ikuko Watanabe; Yumi Hashimoto; Kenji Kurokawa; Iony M Razanajatovo; Keun H Park; Hae K Park; Bok L Lee; Kazuhisa Sekimizu; Yoshinobu Nakanishi
Journal:  Immunology       Date:  2009-10-21       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.